CIMIT-Russia
With funding from the U.S. State Department, the Center for Innovation in Medicine and Technology (CIMIT) convenes research partnerships between Russian and Western scientists. CIMIT-Russia's role is to identify excellent research and research teams, find promising Western scientific collaborators, facilitate initial collaboration and assist development of research programs that can be supported by international research funding. The program also helps Russian institutionsto meet qualifications to receive grants from international scientific funding agencies such as the National Institutes of Health, the World Health Organization and the Wellcome Trust.
The CIMIT-Russia program also promotes commercialization activities by identifying innovative discoveries in these institutions, and leading the institution and scientific teams through a business development process that can result in spin-off companies, joint ventures, and licensing opportunities.
Multi-Drug Resistant Tuberculosis in Russia
The
Brigham and Women's Hospital Division
of Social Medicine and Health Inequalities (DSMHI) faculty
and Partners
In Health (PIH) started an integrated MDR-TB treatment program
(DOTS-Plus) in September 2000 in Tomsk Oblast. Building on this work and
with support from the Eli Lilly Foundation, in 2003 DSMHI
established a center for MDR-TB training and translational research in
Boston and Tomsk, Siberia. The primary objective of the center is to train
physicians from the Russian Federation, where TB is rampant. To date,
more than 200 physicians have been trained in how to diagnose, treat and
control TB.
PIH is a non-profit organization affiliated with the DSMHI at Brigham and Women's Hospital.
Read more
about this project.
PAST PROJECTS
USAID American Schools and Hospitals Abroad Program
In the early 1990's, Brigham and Women's Hospital participated in this USAID sponsored program to send U.S. physicians to Russia to strengthen local medical facilities through professional advice and collaboration.